-
2026 update — How vaping (nicotine e‑cigarettes) affects insulin absorption and blood glucose control: what people with diabetes in the UK need to know
This 2026 update summarises current evidence linking nicotine e‑cigarette use to changes in insulin absorption and blood glucose control. It explains mechanisms, reviews animal and human studies, describes UK guidance, and provides practical steps for people with diabetes.
-
2026 UK comparison: GP smoking‑cessation referrals vs community ‘vape clinics’ — Ealing case study, quit rates and cost‑per‑quitter
This 2026 comparison examines GP smoking‑cessation referrals versus community vape clinics using Ealing’s JSNA data, Swap to Stop evidence and NCSCT guidance. It evaluates quit rates, cost‑per‑quitter, and practical recommendations for commissioners and smokers.
-
2026 UK Training Guide for Vape Shop Staff: Delivering Evidence‑Based Harm‑Reduction Conversations to Help Adult Smokers Switch
This practical 2026 guide helps vape shop staff deliver evidence‑based, harm‑reduction conversations with adult smokers. It summarises updated UK training, key evidence, common misconceptions and practical scripts to support switching while navigating recent policy changes.
-
2026 UK guidance: Measuring secondhand vaping aerosol (PM2.5) and VOCs in pubs — ventilation and monitoring best practice
The 2026 UK guidance sets out standardised monitoring and ventilation targets to control secondhand vaping aerosol (PM2.5) and VOCs in pubs. It recommends continuous PM2.5 monitoring, periodic VOC sampling, and engineered ventilation (minimum 10 L/s/person and higher ACH in busy areas) to reduce spikes that studies have shown can reach mean PM2.5 ≈197 µg/m3 during dense vaping events.